Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DepoCyte (liposomal cytarabine) for CNS relapse in adult ALL or very aggressive lymphoma
2004-004082-15Phase 2Completed
- Sponsor
- Papa Giovanni XXIII Hospital
- Start
- Jul 2007
- Modality
- Small Molecules, Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of liposomal cytarabine in acute lymphoblastic leukemia (ALL), lymphoma and central nervous system involvement by hematologic malignancy, sponsored by Papa Giovanni XXIII Hospital. Started Jul 2007; status: completed.
02
Drugs
liposomal cytarabine
03
Conditions
acute lymphoblastic leukemia (ALL)lymphomacentral nervous system involvement by hematologic malignancy
Beyond the preview
Go deeper on 2004-004082-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004082-15.